Literature DB >> 25832932

Clinical evaluation of Chinese patients with primary distal renal tubular acidosis.

Chunli Zhang1, Hong Ren, Pingyan Shen, Yaowen Xu, Wen Zhang, Weiming Wang, Xiao Li, Yuhuan Ma, Nan Chen.   

Abstract

OBJECTIVE: Distal renal tubular acidosis (dRTA) is a hyperchloremic metabolic acidosis disorder characterized by a normal anion gap with abnormal urinary hydrogen (H(+)) excretion. At present, there are few available reports regarding the clinical status of primary dRTA. The primary objective of this study was to analyze the clinical features and outcomes of primary dRTA.
METHODS: This was a retrospective study performed in patients with primary dRTA who were hospitalized at Ruijin Hospital between March 1996 and July 2009; the clinical features of these patients were analyzed.
RESULTS: This study included 95 consecutive inpatients: 40 men (42.11%) and 55 women (57.89%). Among them, 60 had hypokalemia (63.12%), 29 had complete dRTA and 66 had incomplete dRTA. The mean urine calcium levels of the patients with and without urinary lithiasis were 0.10±0.04 and 0.07±0.05 mmol/24 h・kg, respectively (p=0.04). The blood pH values of the patients with and those without bone disease were 7.37±0.06 and 7.32±0.06, respectively (p=0.01). A total of 8.33% (8/27) of the patients had tubular proteinuria.
CONCLUSION: Hypokalemia is the most common clinical manifestation of primary dRTA. Primary dRTA can also be accompanied by proximal tubular dysfunction. Controlling the urine calcium and citrate levels is crucial for the treatment of nephrocalcinosis and/or nephrolithiasis, while restoring the blood pH to the normal level is essential for controlling bone disease.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25832932     DOI: 10.2169/internalmedicine.54.9421

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

Review 1.  Long-term complications of primary distal renal tubular acidosis.

Authors:  Fernando Santos; Helena Gil-Peña
Journal:  Pediatr Nephrol       Date:  2022-05-11       Impact factor: 3.714

2.  Novel compound heterozygous ATP6V1B1 mutations in a Chinese child patient with primary distal renal tubular acidosis: a case report.

Authors:  Xiangzhong Zhao; Jingru Lu; Yanxia Gao; Xiaoling Wang; Yanhua Lang; Leping Shao
Journal:  BMC Nephrol       Date:  2018-12-17       Impact factor: 2.388

3.  Screening and function discussion of a hereditary renal tubular acidosis family pathogenic gene.

Authors:  Li Chen; Han-Lu Wang; Yao-Bin Zhu; Zhao Jin; Jian-Bin Huang; Xin-Fu Lin; Jie-Wei Luo; Zhu-Ting Fang
Journal:  Cell Death Dis       Date:  2020-03-02       Impact factor: 8.469

4.  Efficacy and safety of an innovative prolonged-release combination drug in patients with distal renal tubular acidosis: an open-label comparative trial versus standard of care treatments.

Authors:  Aurélia Bertholet-Thomas; Catherine Guittet; Maria A Manso-Silván; Arnaud Castang; Véronique Baudouin; Mathilde Cailliez; Massimo Di Maio; Olivia Gillion-Boyer; Emilija Golubovic; Jérôme Harambat; Alexandre Klein; Bertrand Knebelmann; François Nobili; Robert Novo; Ludmila Podracka; Gwenaëlle Roussey-Kesler; Christos Stylianou; Luc-André Granier
Journal:  Pediatr Nephrol       Date:  2020-07-26       Impact factor: 3.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.